TELOMIR PHARMACEUTICALS INC
TELONASDAQ🏆 #3779 by market capEarnings Sep 2US Equity
$1.10▼ $0.03 (−2.74%)
Live1h—
24h▼ 2.7%
7d▼ 4.4%
14d▼ 8.4%
30d▼ 10.3%
1y▼ 30.0%
🏦Market Cap
$76M
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
63
Fair
Earnings
Q2 · 2026Reported 2026-05-13Earnings Per Share
Actual
-0.03
Expected
-0.07
beat
+57.10%
YoY +57.10%
Revenue
Actual
—
Expected
—
—
—
Consensus estimates
Recent quarters
Q2 2026
-0.03
beat
Q1 2026
-0.06
beat
Q4 2025
-0.03
beat
Q3 2025
-0.17
miss